These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 6847786

  • 1. Modification of guanine derivatives by reduced 2-nitroimidazoles.
    Varghese AJ, Whitmore GF.
    Cancer Res; 1983 Jan; 43(1):78-82. PubMed ID: 6847786
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Detection of a reactive metabolite of misonidazole in hypoxic mammalian cells.
    Varghese AJ, Whitmore GF.
    Radiat Res; 1984 Feb; 97(2):262-71. PubMed ID: 6538047
    [Abstract] [Full Text] [Related]

  • 4. Binding of nitroreduction products of misonidazole to nucleic acids and protein.
    Varghese AJ, Whitmore GF.
    Cancer Clin Trials; 1980 Feb; 3(1):43-6. PubMed ID: 7389036
    [Abstract] [Full Text] [Related]

  • 5. Reactions of nucleosides with glyoxal and acrolein.
    Shapiro R, Sodum RS, Everett DW, Kundu SK.
    IARC Sci Publ; 1986 Feb; (70):165-73. PubMed ID: 3793171
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cellular and chemical reduction products of misonidazole.
    Varghese AJ, Whitmore GF.
    Chem Biol Interact; 1981 Aug; 36(2):141-51. PubMed ID: 7273240
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reactions of 9-substituted guanines with bromomalondialdehyde in aqueous solution predominantly yield glyoxal-derived adducts.
    Ruohola AM, Koissi N, Andersson S, Lepistö I, Neuvonen K, Mikkola S, Lönnberg H.
    Org Biomol Chem; 2004 Jul 07; 2(13):1943-50. PubMed ID: 15227548
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on the action of nitroimidazole drugs. The products of nitroimidazole reduction.
    Knox RJ, Knight RC, Edwards DI.
    Biochem Pharmacol; 1983 Jul 15; 32(14):2149-56. PubMed ID: 6870942
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic properties of hydroxylamino- and amino-misonidazole, possible metabolic products of misonidazole, in hypoxic HeLa S3 cells.
    Murayama C, Hori H, Mori T, Inayama S.
    Gan; 1983 Oct 15; 74(5):693-8. PubMed ID: 6642142
    [Abstract] [Full Text] [Related]

  • 13. Biochemistry of misonidazole reduction by NADPH-cytochrome c (P-450) reductase.
    Heimbrook DC, Sartorelli AC.
    Mol Pharmacol; 1986 Feb 15; 29(2):168-72. PubMed ID: 3005827
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Induction of DNA strand breaks by reduced nitroimidazoles. Implications for DNA base damage.
    Silver AR, McNeil SS, O'Neill P, Jenkins TC, Ahmed I.
    Biochem Pharmacol; 1986 Nov 15; 35(22):3923-8. PubMed ID: 3778516
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glutathione conjugates of misonidazole.
    Varghese AJ.
    Biochem Biophys Res Commun; 1983 May 16; 112(3):1013-20. PubMed ID: 6847675
    [Abstract] [Full Text] [Related]

  • 20. N-oxidation: a possible route of tinidazole metabolism in man.
    Coker HA, Essien EE, Edoho EJ.
    Afr J Med Med Sci; 1990 Jun 16; 19(2):111-4. PubMed ID: 2115725
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.